Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

被引：0
|
作者：
Matthias Uhl
Lutz Edler
Alexandra D Jensen
Gregor Habl
Jan Oelmann
Falk Röder
Oliver Jäckel
Jürgen Debus
Klaus Herfarth
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] Heidelberg Ion Therapy Center (HIT),undefined
[3] German Cancer Research Center (dkfz),undefined
来源：
Radiation Oncology | / 9卷
关键词：
Sacral chordoma; Chordoma; Carbon ion therapy; Proton therapy; Irradiation; Randomized trial; Hypofractionation; Heavy ion therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I/II trial of carbon-ion therapy for patients with locally recurrent rectal cancer.
    Yamada, S
    Kamada, T
    Yasuda, S
    Tsujii, H
    Ochiai, T
    Koda, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 280S - 280S
  • [42] Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial
    Toesca, Diego A. S.
    Hartsell, William F.
    Dewees, Todd A.
    Chang, John H.
    Laughlin, Brady S.
    Voss, Molly M.
    Dodoo, Christopher A.
    Mohammed, Nasiruddin
    Keole, Sameer R.
    Mcgee, Lisa A.
    Gondi, Vinai
    Sweeney, Patrick J.
    Dorn, Paige
    Sinesi, Christopher C.
    Doh, Lucius S.
    Rich, Tyvin
    Vargas, Carlos E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (05): : 1377 - 1385
  • [43] Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
    Combs, Stephanie E.
    Kieser, Meinhard
    Rieken, Stefan
    Habermehl, Daniel
    Jaekel, Oliver
    Haberer, Thomas
    Nikoghosyan, Anna
    Haselmann, Renate
    Unterberg, Andreas
    Wick, Wolfgang
    Debus, Juergen
    BMC CANCER, 2010, 10
  • [44] Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial
    Gillespie, Erin F.
    Yang, Joanna C.
    Mathis, Noah J.
    Marine, Catherine B.
    White, Charlie
    Zhang, Zhigang
    Barker, Christopher A.
    Kotecha, Rupesh
    McIntosh, Alyson
    Vaynrub, Max
    Bartelstein, Meredith K.
    Mitchell, Aaron
    Guttmann, David M.
    Yerramilli, Divya
    Higginson, Daniel S.
    Yamada, Yoshida J.
    Kohutek, Zachary A.
    Powell, Simon N.
    Tsai, Jillian
    Yang, Jonathan T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 38 - +
  • [45] Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
    Stephanie E Combs
    Meinhard Kieser
    Stefan Rieken
    Daniel Habermehl
    Oliver Jäkel
    Thomas Haberer
    Anna Nikoghosyan
    Renate Haselmann
    Andreas Unterberg
    Wolfgang Wick
    Jürgen Debus
    BMC Cancer, 10
  • [46] A Phase I/II Clinical Trial of Carbon Ion Therapy for Patients With Locally Advanced Pancreas Cancer (Protocol 0204, 12 Fractions/3 Weeks)
    Shinoto, M.
    Yamada, S.
    Kato, H.
    Yasuda, S.
    Imada, H.
    Kamada, T.
    Tsujii, H.
    Saisyo, H.
    PANCREAS, 2009, 38 (08) : 1047 - 1047
  • [47] Phase 1/2 Trial of Definite Carbon Ion Radiation Therapy for Prostate Cancer: Evaluation of Hypofractionated Treatment of 12 Fractions Over 3 Weeks
    Nomiya, T.
    Tsuji, H.
    Maruyama, K.
    Kamada, T.
    Hirohiko, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S408 - S408
  • [48] Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer
    Hoffman, K. E.
    Voong, K. R.
    Levy, L. B.
    Pugh, T. J.
    Choi, S.
    Du, W.
    Frank, S. J.
    Johnson, J. L.
    Kudchadker, R.
    Nguyen, Q. N.
    Lee, A.
    Mahmood, U.
    McGuire, S. E.
    Kuban, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S32 - S32
  • [49] Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Results of the SHIVA trial
    Le Tourneau, Christophe
    Delord, Jean-Pierre
    Goncalves, Anthony
    Gavoille, Celine
    Dubot, Coraline
    Isambert, Nicolas
    Campone, Mario
    Tredan, Olivier
    Mauborgne, Cecile
    Armanet, Sebastien
    Servant, Nicolas
    Bieche, Ivan
    Bernard, Virginie
    Gentien, David
    Jezequel, Pascal
    Attignon, Valery
    Boyault, Sandrine
    Vincent-Salomon, Anne
    Kamal, Maud
    Paoletti, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
    Anna V Nikoghosyan
    Geraldine Rauch
    Marc W Münter
    Alexandra D Jensen
    Stephanie E Combs
    Meinhard Kieser
    Jürgen Debus
    BMC Cancer, 10
12345